Social Monitoring: How the FDA Mined Social Media to Gain Diabetes Insights
Dr Christine Lee discusses her work on how to capture the patient’s voice by using multiple data sources, such as unstructured FDA archival data and social media.
Metabolic
METABOLIC
Featured Article
Latest News
Circulating Cholesterol Levels and Early-Onset AD: Is There a Link?
Study showed an association between early-onset Alzheimer disease and higher levels of low-density lipoprotein cholesterol independent of the effects of APOE, as well as demonstrated enrichment of rare coding variants of APOB.
Statin Use Linked to Lower Levels of Sex Hormones in Multi-Ethnic Cohort
Considering more individuals are eligible for statin therapy based on 2018 cholesterol guidelines, it is important to examine the possibility that the medication may impair gonadal steroidogenesis.
Review Suggests More Sleep May Lower Cardiometabolic Risk
Increasing the length of nightly sleep may help reduce the risk for cardiovascular disease and metabolic disorders.
Evolocumab Safely Reduces Risk for CV Events in Chronic Kidney Disease
PCSK9 inhibition with evolocumab was safe and more effective than statin monotherapy in reducing LDL-C in stable individuals with moderate CKD and clinically evident atherosclerosis.
High Fat Mass During Adolescence Linked to Increased Arterial Stiffness
Persistently high fat mass during adolescence is associated with greater arterial stiffness.
No Increased CV Risk for Linagliptin vs Glimepiride in Type 2 Diabetes
Boehringer Ingelheim and Lilly announced full data from the CAROLINA trial demonstrating that linagliptin, a DPP-4 inhibitor, did not increase CV risk.
Irregular Sleep Patterns May Increase Risk for Metabolic Syndrome
Variability in sleep duration and timing is associated with higher odds of metabolic syndrome.
Lowering Cholesterol Levels May Worsen Nerve Damage in Type 2 Diabetes
Lowering serum cholesterol levels in patients with type 2 diabetes is associated with diabetic polyneuropathy.
Blood Donor Screening: A Novel Method of Identifying Familial Hypercholesterolemia
Blood donor screening may serve as a novel strategy for the early diagnosis of familial hypercholesterolemia.
Nonfasting Lipid Levels Adequate for Assessing Cardiovascular Risk
Fasting before a cholesterol test is not necessary when evaluating risk for cardiovascular events.
Want to read more?
Please login or register first to view this content.
Next post in Dyslipidemia
